Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET.

Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET. Abstract Text:

Muneo Ohba,Ryohei Hosokawa,Naoshige Kambara,Eiji Tadamura,Marcelo Mamede,Shigeto Kubo,Masaki Yamamuro,Masatoshi Fujita,Takeshi Kimura,Ryuji Nohara,Toru Kita,Muneo Ohba,Ryohei Hosokawa,Naoshige Kambara,Eiji Tadamura,Marcelo Mamede,Shigeto Kubo,Masaki Yamamuro,Masatoshi Fujita,Takeshi Kimura,Ryuji Nohara,Toru Kita,

BACKGROUND: The clinical features of patients with the dilated phase of hypertrophic cardiomyopathy (DHCM) may resemble those of patients with dilated cardiomyopathy (DCM); that is, systolic dysfunction and left ventricular dilatation. Myocardial flow reserve (MFR) is impaired in patients with nonischemic cardiomyopathy, and the reduced MFR may be related to poor prognosis. Several studies report that the mortality rate for patients with DHCM is higher than for DCM, but the difference between these 2 cardiomyopathies is still unclear. The purpose of this study was to assess the MFR of these 2 cardiomyopathies, using (15)O-water positron emission tomography (PET) to elucidate their differences. METHODS AND RESULTS: In total 30 patients were investigated: 23 with DCM (Group A) and 7 with DHCM (Group B). All those who were in a stable condition underwent cardiac catheterization. Myocardial blood flow (MBF) at rest and under ATP infusion was measured by (15)O-water PET, and the MFR was calculated. There were no significant differences in the hemodynamics of the 2 groups. The mean MFR in DHCM was significantly lower than that in DCM (1.49+/-0.31 vs 2.62+/-1.08; p=0.042), whereas MBF at rest did not differ (DCM vs DHCM: 0.66+/-0.20 vs 0.49+/-0.05 ml . min(-1) . g(-1); NS). The MFR in both Group A and B was significantly decreased compared with the normal controls (MFR in normal controls: 5.15+/-1.64, p=0.00015, 0.00013, respectively). CONCLUSIONS: These results suggest that impaired vasodilatation (ie, dysfunction of the microcirculation) is more severe in patients with DHCM than in patients with DCM, even though patients' characteristics and hemodynamics do not differ.

Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET. Publishing Authors By Initials

M Ohba,R Hosokawa,N Kambara,E Tadamura,M Mamede,S Kubo,M Yamamuro,M Fujita,T Kimura,R Nohara,T Kita,M Ohba,R Hosokawa,N Kambara,E Tadamura,M Mamede,S Kubo,M Yamamuro,M Fujita,T Kimura,R Nohara,T Kita,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Circulation journal : official journal of the Japa

VOLUME: 71

Page Numbers: 884-90

Journal Abbreviation: Circ. J.

ISSN: 1346-9843

DAY: 28

MONTH: Jun

YEAR: 2007

Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101137683

Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET.

AFFILIATION: Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Circ J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET Related Publications

• A role of NKT cells in HCV infection and development of hepatocellular carcinoma: Are they protective or destructive?
• Adnexal torsion of mature cystic teratoma with hemorrhagic infarction: helpful findings on successive plain abdominal radiographs.
• Autoreactive CD8-specific T-cell response in primary biliary cirrhosis.
• CD66b regulates adhesion and activation of human eosinophils.
• Concise total synthesis of (-)-spongotine A.
• Coronary Buerger's disease with a peripheral arterial aneurysm.
• Crystallization and some properties of 3,4-dihydroxyphenylacetate 2,3-oxygenase from Pseudomonas ovalis.
• Decreased arachidonate metabolism in mouse peritoneal macrophages after foam cell transformation with oxidized low-density lipoproteins.
• Degradation of mating factor by alpha-mating type cells of Saccharomyces cerevisiae.
• Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET.
• Direct evidence for two distinct forms of the flavoprotein subunit of human mitochondrial complex II (succinate-ubiquinone reductase).
• Evaluation of diagnostic methods for Candida albicans translocation in a mouse model: seminested polymerase chain reaction, blood culture, and serological assays.
• Family study in PBC as a clue to the possible involvement of genetic and environmental factors.
• Globus pallidus external segment.
• Human complex II (succinate-ubiquinone oxidoreductase): cDNA cloning of the flavoprotein (Fp) subunit of liver mitochondria.
• New perspective for natural products synthesis: concise synthesis of (+)-sch 642305 by chiral auxiliary multiuse methodology.
• Optical rotatory dispersion and circular dichroism of horse myoglobin and its derivatives.
• Organic chemistry using weakly electrophilic salts: efficient formation of O,O-mixed, O,S- and N,O-acetals.
• PBC and eosinophilia: New insight from autoantibody response.
• Pharmacologic investigation of the mechanism underlying cold allodynia using a new cold plate procedure in rats with chronic constriction injuries.
• Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population.
• Repetitive activation of glutamatergic inputs evokes a long-lasting excitation in rat globus pallidus neurons in vitro.
• Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium.
• The role of ubiquitous airborne fungi in chronic rhinosinusitis.
• Total synthesis of (+/-)-gamma-rubromycin on the basis of two aromatic Pummerer-type reactions.
• Unexpected highly chemoselective deprotection of the acetals from aldehydes and not ketones: TESOTf-2,6-lutidine combination.
• Up-regulation of heme biosynthesis during differentiation of Neuro2a cells.
• Versatile direct dehydrative approach for diaryliodonium(III) salts in fluoroalcohol media.
• [A case of brainstem encephalitis following multiple cranial neuropathy in a hepatocellular carcinoma patient--association with cytomegalovirus and varicella-zoster virus infection]
• [Development of artificial implant bone]